Executives
?
Levitz Michael L
EVP, CFO, Treasurer
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK
1468019
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
20,423
Price per Share :
$16.19
Equivalence :
$330,648.37
Transaction History
-
M20,423 Shares After TransactionValue : $n/a$0.0Transaction Date : 08/10/22
-
Footnotes
-
-
Footnotes:#1 Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest.#2 Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
-
M34,365 Shares After TransactionValue : $n/a$0.0Transaction Date : 08/10/23
-
Footnotes
-
-
Footnotes:#1 Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023.#2 Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023.#3 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020.#4 Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
F33,232 Shares After TransactionValue : $617,450.56$21,051.14Transaction Date : 08/10/23
-
Footnotes
-
-
Footnotes:#1 Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023.#2 Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023.#3 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020.#4 Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
M37,830 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.#2 Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.#3 Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#5 Reflects the first vesting installment of RSUs granted on March 9, 2023.#6 Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
-
F36,527 Shares After TransactionValue : $928,516.34$33,122.26Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.#2 Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.#3 Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#5 Reflects the first vesting installment of RSUs granted on March 9, 2023.#6 Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.